Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 1:17 AM
NCT ID:
NCT06645093
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with diffuse large B-cell lymphoma planned to receive R-CHOP (rituximab, vincristine, doxorubicin, cyclophosphamide, and prednisolone) and Hodgkin lymphoma receiving ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine)
* Age ≥ 18 years
* ECOG status 0-2
* Normal weight and overweight (BMI ≥ 18,5 kg/m\^2)
Exclusion Criteria:
* Receiving concurrent radiation therapy and/or treatment
* Other concomitant disease that may make intermittent fasting complicated such as diabetes mellitus
* ECOG status: \> 3
* BMI \< 18,5 kg/m2
* Age \> 80 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06645093
Study Brief:
Protocol Section:
NCT06645093